United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 245,136 | 243,817 | 242,468 | 225,577 | 204,214 |
| Cost of Goods | 29,313 | 37,665 | 27,968 | 29,633 | 24,031 |
| Gross Profit | 215,823 | 206,152 | 214,500 | 195,944 | 180,183 |
| Operating Expenses | 122,099 | 78,214 | 134,749 | 90,990 | 73,477 |
| Operating Income | 94,037 | 128,603 | 80,719 | 105,587 | 106,737 |
| Interest Expense | 4,436 | 4,490 | 4,384 | 3,879 | 3,886 |
| Other Income | 1,234 | 839 | 32,158 | 1,582 | 1,085 |
| Pre-tax Income | 90,835 | 124,952 | 108,493 | 103,290 | 103,936 |
| Income Tax | 28,510 | 41,697 | 30,382 | 30,974 | 33,176 |
| Net Income Continuous | 62,325 | 83,255 | 78,111 | 72,316 | 70,760 |
| Net Income | $62,325 | $83,255 | $78,111 | $72,316 | $70,760 |
| EPS Basic Total Ops | 1.24 | 1.63 | 1.52 | 1.37 | 1.32 |
| EPS Basic Continuous Ops | 1.24 | 1.64 | 1.52 | 1.37 | 1.32 |
| EPS Diluted Total Ops | 1.19 | 1.62 | 1.46 | 1.34 | 1.29 |
| EPS Diluted Continuous Ops | 1.19 | 1.63 | 1.46 | 1.34 | 1.29 |
| EBITDA(a) | $106,291 | $139,356 | $91,601 | $116,059 | $117,443 |